Related Experiment Video
Updated: May 17, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Desmopressin-induced posterior reversible encephalopathy syndrome
Ruili Wei1, Lu Jin, Jianhe Huang
1Brain Medical Center, First Affiliated Hospital, Zhejiang University School of Medicine, China.
Abstract:
We herein report the case of a patient who presented with an acute decrease of visual acuity, hypertension, focal seizures and transient mental dysfunction while undergoing desmopressin treatment. Neuroimaging revealed bilateral occipital-parietal lesions that presented with vasogenic edema. After controlling the hypertension and discontinuing the desmopressin treatment, the patient's condition improved. A follow-up imaging examination performed six months later showed complete resolution of the lesions. It is important to recognize posterior reversible encephalopathy syndrome (PRES) as a rare and serious complication of desmopressin administration. Both the blood pressure and water electrolyte balance should be carefully monitored in patients receiving desmopressin therapy.
Related Concept Videos
Hepatic Encephalopathy
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Diabetes Insipidus I: Introduction
Diabetes Insipidus II: Pathophysiology
